{"gene":"FGF4","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":1998,"finding":"FGF4 promotes proliferation of trophoblast stem cells; in the absence of FGF4, trophoblast stem cell lines differentiate to other trophoblast subtypes in vitro, establishing FGF4 as a required maintenance signal for trophoblast stem cell self-renewal.","method":"Trophoblast stem cell culture with/without FGF4; in vivo chimera assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO rescue experiments plus stem cell culture with defined phenotypic readouts, replicated across multiple labs","pmids":["9851926"],"is_preprint":false},{"year":1995,"finding":"FGF-4 gene expression requires synergistic action of Sox2 and Oct-3 binding to adjacent sites on the FGF-4 enhancer; Sox2 forms a ternary complex with either Oct-1 or Oct-3 on the enhancer DNA, but only the Sox2/Oct-3 complex drives transcriptional activation, identifying FGF4 as the first known target gene for Oct-3 and Sox factors.","method":"cDNA cloning, gel-shift (EMSA), transcriptional reporter assays, transfection into EC cells","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods (EMSA, reporter assays, mutagenesis) in one rigorous study; widely replicated","pmids":["7590241"],"is_preprint":false},{"year":1995,"finding":"FGF-4 is required for postimplantation mouse development; Fgf4-null embryos fail to proliferate the inner cell mass after implantation, and this proliferative defect is rescued by exogenous FGF-4 protein in culture.","method":"Gene targeting (knockout mouse), embryo culture with FGF-4 rescue","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined cellular phenotype plus protein rescue; replicated by subsequent studies","pmids":["7809630"],"is_preprint":false},{"year":1993,"finding":"FGF-4 protein stimulates proliferation of limb bud mesenchyme (pro-outgrowth), while BMP-2 inhibits limb growth; the extent of limb outgrowth can be modulated by mixing the two signals, demonstrating that limb growth is regulated by a balance of AER-derived stimulatory (FGF-4) and inhibitory (BMP-2) signals.","method":"In vitro limb bud culture system with FGF-4 and BMP-2 protein addition","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct in vitro functional assay with dose-response mixing experiment; replicated by multiple studies","pmids":["8421496"],"is_preprint":false},{"year":1999,"finding":"FGF4 signaling from the posterior AER maintains the polarizing region (SHH/FGF4 feedback loop); the BMP antagonist Gremlin relays the SHH signal from the polarizing region to the AER to induce Fgf4 expression; Gremlin-expressing cell grafts rescue Fgf4 expression and restore the feedback loop in limb deformity mutants.","method":"Genetic analysis of Shh-null and limb deformity mutant embryos; cell grafting experiments; in situ hybridization","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in multiple mutant backgrounds plus rescue by cell grafting; two orthogonal approaches","pmids":["10524628"],"is_preprint":false},{"year":2000,"finding":"Conditional inactivation of Fgf4 alone in mouse limbs does not disrupt Shh expression or limb formation, contradicting the SHH/FGF4 feedback loop model; instead, Fgf9 and Fgf17 (but not Fgf8) expression in the AER is dependent on Shh, indicating that combined AER-FGF activities—not FGF4 alone—maintain the feedback loop with Shh.","method":"Conditional gene targeting (Cre/lox) of Fgf4 in AER; in situ hybridization of downstream targets","journal":"Nature Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with in situ readouts; directly contradicts prior model and is a rigorous negative result","pmids":["10802662"],"is_preprint":false},{"year":2004,"finding":"FGF4 can functionally replace FGF8 in limb skeletal development; when Fgf4 is expressed in place of Fgf8 via conditional allele swap, all skeletal defects caused by Fgf8 loss are rescued. Simultaneous loss of both Fgf4 and Fgf8 in the AER causes failure of limb bud mesenchyme survival, with nearly abolished Shh and Fgf10 expression.","method":"Conditional Cre-mediated allele swap (Fgf4 gain-of-function + Fgf8 loss-of-function); double conditional knockout; skeletal analysis","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional allele replacement plus double KO with defined skeletal and molecular phenotypes; two orthogonal approaches","pmids":["15328019"],"is_preprint":false},{"year":2012,"finding":"FGF4 is required for lineage restriction of primitive endoderm (PrE) in the blastocyst ICM; Fgf4-null ICMs initiate co-expression of EPI and PrE markers but fail to achieve salt-and-pepper segregation and exclusive NANOG or GATA6 expression, establishing FGF4/ERK signaling as the mechanism for lineage bias acquisition rather than initial lineage marker activation.","method":"Zygotic and maternal/zygotic Fgf4 conditional knockout; immunofluorescence for NANOG/GATA6; exogenous FGF rescue experiments","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with quantitative immunofluorescence phenotyping plus rescue; multiple alleles tested","pmids":["23193166"],"is_preprint":false},{"year":2011,"finding":"FGF4 and FGF8 together constitute the wavefront signal that maintains presomitic mesoderm (PSM) in an undifferentiated state during somitogenesis; double deletion of Fgf4 and Fgf8 in the PSM abolishes expression of cycling genes, WNT pathway genes, and PSM progenitor markers, causing premature differentiation of the entire PSM. FGF signaling maintains WNT signaling and operates independently of WNT in parallel.","method":"Double conditional Fgf4/Fgf8 knockout in PSM; in situ hybridization; WNT pathway rescue experiments","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — double conditional KO with molecular phenotyping and genetic epistasis with WNT pathway; multiple orthogonal readouts","pmids":["21368122"],"is_preprint":false},{"year":2012,"finding":"FGF4 and FGF8 signaling are required for axial elongation after gastrulation; combined loss of Fgf8 and Fgf4 during late gastrulation causes severe vertebral phenotype and failure to maintain epiblast progenitors that generate paraxial mesoderm, with reduced Wnt3a, Brachyury, and NOTCH pathway gene expression.","method":"Double conditional knockout; skeletal analysis; gene expression analysis","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — double conditional KO with skeletal and molecular phenotypes; two orthogonal methods","pmids":["22954964"],"is_preprint":false},{"year":1988,"finding":"The hst-1 (FGF4) transforming protein, expressed in insect cells, is a secreted heparin-binding growth factor of ~18 kDa that stimulates DNA synthesis in NIH3T3 cells and endothelial cell proliferation, and induces anchorage-independent growth.","method":"Baculovirus expression in BmN cells; heparin-affinity purification; mitogenesis assay; soft agar assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — protein purification and direct biochemical characterization; replicated by subsequent studies","pmids":["2978866"],"is_preprint":false},{"year":1991,"finding":"K-fgf/hst transformation of NIH 3T3 cells occurs via an autocrine mechanism requiring extracellular receptor activation; deletion of the signal peptide or retention of K-FGF in the ER/Golgi markedly reduces focus-forming ability, and anti-K-FGF neutralizing antibodies reverse the transformed phenotype, demonstrating that secretion and extracellular receptor engagement are required.","method":"Signal peptide deletion mutants; KDEL retention mutant; neutralizing antibody reversal; soft agar growth assay","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of secretory pathway signals plus antibody neutralization; multiple orthogonal methods in one study","pmids":["1990270"],"is_preprint":false},{"year":1989,"finding":"NIH 3T3 cells transformed by hst/K-fgf show downregulation of FGF receptors, and this transformation is reversed by suramin (which blocks FGF-receptor interaction), indicating that K-FGF transforms cells through autocrine activation of its receptor and that K-FGF and bFGF may share the same receptor.","method":"125I-bFGF receptor binding assay; suramin treatment; focus formation and transformation assays","journal":"Journal of Cell Biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — receptor binding assay plus pharmacological reversal plus comparison with control oncogene; two orthogonal methods","pmids":["2553749"],"is_preprint":false},{"year":2001,"finding":"FGF-4 binds heparan sulfate (HS) in a tissue-specific manner requiring a distinct HS sulfation pattern different from FGF-2; FGF-4 fails to bind HS or activate signaling in vascular tissues. FGFR2-IIIc binds all FGF-4/HS complexes, but FGFR1-IIIc fails to bind FGF-4/HS in most tissues, establishing that tissue-specific HS sulfation patterns differentially control FGF-4 signaling.","method":"FGF-4 and FGFR ectodomain probing of embryonic tissue sections; BaF3 cell proliferation assays with FR1c or FR2c","journal":"Journal of Cell Biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct tissue-binding and cell-based functional assays with ectodomain constructs; two orthogonal approaches","pmids":["11724824"],"is_preprint":false},{"year":2009,"finding":"PARP1 binds the FGF4 enhancer, positively regulates FGF4 expression, and poly(ADP-ribosyl)ates Sox2, promoting dissociation/degradation of inhibitory Sox2 from the FGF4 enhancer; inhibition of PARP1 increases Sox2 occupancy at the FGF4 enhancer and reduces FGF4 expression, while Sox2 knockdown abrogates the inhibitory effect of PARP1 inhibitors on FGF4.","method":"ChIP on FGF4 enhancer; Co-IP of PARP1 with Oct4/Sox2; in vitro poly(ADP-ribosyl)ation assay; siRNA knockdown; PARP1 inhibitor treatment","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — biochemical PTM assay plus ChIP plus genetic rescue; multiple orthogonal methods in one study","pmids":["19531481"],"is_preprint":false},{"year":2013,"finding":"PARP1/ARTD1-mediated poly(ADP-ribosyl)ation (PARylation) of Sox2 promotes Sox2 binding to the Fgf4 enhancer and activates Fgf4 expression during early reprogramming; Artd1-deficient fibroblasts show strongly decreased reprogramming capacity, and exogenous FGF4 (days 2–4) restores reprogramming efficiency in Artd1-null cells.","method":"Artd1-/- fibroblast reprogramming; Fgf4 reporter assays; FGF4 rescue experiment; ChIP","journal":"Stem Cells","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with phenotype plus FGF4 rescue plus ChIP; multiple orthogonal methods replicating PMID 19531481","pmids":["23939864"],"is_preprint":false},{"year":1993,"finding":"FGF-4 can induce Evx-1 (a homeobox gene normally regulated by AER signals) expression in limb bud mesenchyme; this induction is indirect (blocked by protein synthesis inhibitor) and is modulated by BMP-2, positioning Evx-1 as a downstream target in the FGF-4 signal transduction pathway in the limb.","method":"In vitro limb bud culture; cycloheximide (protein synthesis inhibitor) block; BMP-2 co-treatment","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional in vitro culture with pharmacological inhibition; single lab, two orthogonal approaches","pmids":["7506139"],"is_preprint":false},{"year":1994,"finding":"FGF-4 protein can substitute for the AER to allow virtually normal limb outgrowth and patterning after AER removal in chick limb; FGF-4 stimulates proliferation of limb mesenchyme and maintains polarizing region activity.","method":"AER removal + FGF-4 protein bead implant in ovo; DiI cell labeling; skeletal analysis","journal":"Molecular Reproduction and Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo rescue assay with protein beads; single lab with defined phenotypic readout","pmids":["7999365"],"is_preprint":false},{"year":1999,"finding":"FGF-4 acts as a potent chemoattractive agent for limb bud mesenchymal cells in a dose-dependent manner; this chemotactic activity is independent of FGF-4's ability to induce Shh expression. The AER exerts chemoattractive function on subapical cells during limb outgrowth, partly mediated by FGF-4 production.","method":"DiI cell labeling + FGF-4 bead implantation; partial AER removal; cell migration tracking","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cell migration assay with dose-response and AER removal; single lab","pmids":["10395792"],"is_preprint":false},{"year":2001,"finding":"FGFR2-IIIb acts upstream of Shh and Fgf4 in the limb; Fgfr2-IIIb knockout mice lack Shh and Fgf4 expression in limb buds despite normal Fgf8, Fgf10, Bmp4, and Msx1, placing Shh and Fgf4 induction as downstream targets of FGFR2-IIIb signaling.","method":"Fgfr2-IIIb knockout mouse; in situ hybridization for downstream targets","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with in situ hybridization of multiple downstream targets; single lab but clean epistasis","pmids":["11180951"],"is_preprint":false},{"year":2002,"finding":"FGF4 is a direct transcriptional target of LEF1/Wnt signaling; FGF4 beads fully rescue developmental arrest of Lef1-null tooth germs, and FGF4 induces Fgf3 in dental mesenchyme and subsequently Shh in epithelium, establishing an FGF4-dependent signal relay cascade in tooth development.","method":"LEF1 knockout analysis; FGF4 protein bead rescue in Lef1-/- tooth germs; LEF1 ChIP/reporter assay; in situ hybridization for downstream targets","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic rescue plus direct target identification plus signaling cascade analysis; multiple orthogonal methods","pmids":["12502739"],"is_preprint":false},{"year":2010,"finding":"FGF4 signaling through FRS2α activates ERK and enhances Cdx2 expression in trophoblast stem cells; Cdx2 then binds an FGF4-responsive enhancer in the Bmp4 promoter to drive Bmp4 production; exogenous Bmp4 rescues defective growth of Frs2α-null ICM, establishing an FGF4→FRS2α→ERK→Cdx2→Bmp4 paracrine axis between trophectoderm and ICM.","method":"FRS2α knockout ESC/TS cells; ERK activation assay; Cdx2 ChIP on Bmp4 promoter; Bmp4 rescue of Frs2α-null ICM","journal":"Stem Cells","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP plus genetic KO plus rescue experiment; multiple orthogonal methods establishing pathway order","pmids":["19890878"],"is_preprint":false},{"year":2002,"finding":"Fgf4 expressed in muscle positively regulates scleraxis and tenascin expression in chick limb tendons; in muscleless and aneural limbs, these tendon markers are down-regulated, and exogenous FGF4 bead implantation induces scleraxis and tenascin but not Fgf8 in normal, aneural, and muscleless limbs.","method":"Muscleless/aneural limb preparation; FGF4 bead implantation; in situ hybridization for tendon markers","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function (muscleless limb) plus gain-of-function (bead implant) with defined molecular readouts; single lab","pmids":["12086472"],"is_preprint":false},{"year":2001,"finding":"Misexpression of Fgf-4 in chick limb inhibits myogenesis by downregulating Frek (an FGF receptor expressed in myoblasts) expression; retroviral overexpression of Fgf-4 reduces muscle cell number and inhibits terminal myogenic differentiation in vivo.","method":"RCAS retroviral overexpression of Fgf-4; quail/chick transplantation; in situ hybridization for Frek and muscle markers","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function in vivo with cell fate tracking and molecular readouts; single lab","pmids":["11319857"],"is_preprint":false},{"year":1994,"finding":"FGF-4 produced by undifferentiated ICM cells promotes differentiation and migration of parietal endoderm from ICM outgrowths (increasing 92 kDa gelatinase and tPA secretion), and FGFR-3 and FGFR-4 are expressed in blastocyst cells as receptors for FGF-4.","method":"Immunosurgical ICM isolation; ICM culture with recombinant FGF-4; gelatinase/tPA secretion assay; receptor expression analysis","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct culture experiment with protein addition and functional readouts; single lab","pmids":["7925026"],"is_preprint":false},{"year":1997,"finding":"FGF-4 does not act as an autocrine growth factor for ES cells in culture; FGF-4-/- ES cells proliferate normally and form complex teratomas. However, FGF-4 is required for the growth/survival of specific differentiated lineages (particularly parietal extraembryonic endoderm) derived from ES cells in vitro.","method":"Homologous recombination to generate FGF-4-/- ES cells; proliferation assay; retinoic acid differentiation; FGF-4 rescue","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO ES cells with defined differentiation phenotype plus FGF-4 protein rescue; single lab","pmids":["9441693"],"is_preprint":false},{"year":2009,"finding":"Fgf4 is required for left-right (LR) patterning of visceral organs in zebrafish; Fgf4 knockdown randomizes organ laterality and is required for cilia formation in Kupffer's vesicle and for expression of lefty1 in the posterior notochord, establishing a role for Fgf4 in LR axis establishment distinct from Fgf8.","method":"Morpholino antisense knockdown of Fgf4 in zebrafish; in situ hybridization for laterality markers (lefty1, lefty2, southpaw, pitx2); cilia analysis in Kupffer's vesicle","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — morpholino knockdown with specific molecular phenotype; single lab but multiple orthogonal readouts","pmids":["19481538"],"is_preprint":false},{"year":1996,"finding":"FGF-4 (hst/HST-1) causes dose-dependent prolactin secretion from rat pituitary cells and increases prolactin transcriptional activity via the rPRL promoter; stable hst transfection of GH4 cells causes enhanced basal PRL secretion, faster proliferation, and more aggressive tumor growth in vivo.","method":"Recombinant FGF-4 treatment of pituitary cell cultures; stable transfection of hst; PRL reporter luciferase assay; subcutaneous tumor injection","journal":"Journal of Clinical Investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function transfection plus reporter assay plus in vivo tumor model; single lab","pmids":["8550832"],"is_preprint":false},{"year":2017,"finding":"O-GlcNAcylation of PKCζ at its phosphorylation site inhibits PKCζ phosphorylation (activation), thereby inhibiting the FGF4-PKCζ-MEK-ERK1/2 signaling pathway in mouse ESCs and maintaining the undifferentiated state.","method":"O-GlcNAc site mapping on PKCζ; phosphorylation assays; MEK/ERK1/2 activity measurements; OGT inhibition and overexpression in ESCs","journal":"Stem Cell Reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — PTM identification with functional pathway readout; single lab, multiple biochemical methods","pmids":["29249667"],"is_preprint":false},{"year":1994,"finding":"Adenovirus-mediated HST-1 (FGF4) gene transfer in nude mice specifically increases peripheral platelet count and megakaryocyte numbers in bone marrow, with no other major hematological changes.","method":"Adenovirus-mediated gene delivery in vivo; complete blood counts; bone marrow histology","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function with specific cellular phenotype; single lab","pmids":["7809043"],"is_preprint":false},{"year":1994,"finding":"HST-1 (FGF4) protein has potent in vivo angiogenic activity demonstrated in the chick chorioallantoic membrane assay and rat cornea assay; NIH3T3 transformants expressing hst-1 form highly vascularized tumors in nude mice.","method":"E. coli-expressed recombinant hst-1 protein; CAM angiogenesis assay; rat cornea assay; xenograft tumor model","journal":"Cancer Letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal in vivo angiogenesis assays plus xenograft; single lab","pmids":["7520355"],"is_preprint":false},{"year":2022,"finding":"FGF4 protects the liver from NAFLD/NASH by activating hepatic FGFR4, which triggers a Ca2+/CaMKKβ-dependent AMPK-Caspase 6 signaling axis, leading to enhanced fatty acid oxidation and reduced hepatocellular apoptosis.","method":"Hepatic Fgf4 knockout and recombinant FGF4 pharmacological administration in mouse NAFLD/NASH models; FGFR4-specific inhibition; AMPK and Caspase 6 activity assays","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus pharmacological rescue plus pathway inhibition; single lab with multiple orthogonal methods","pmids":["35152446"],"is_preprint":false},{"year":2024,"finding":"Hepatic FXR directly targets Fgf4 as a paracrine regulator of bile acid homeostasis; FGF4 signals through FGFR4 to activate an intracellular FGFR4-LRH-1 node that downregulates Cyp7a1 and Cyp8b1, acting as a first-line checkpoint for intrahepatic BA flux upstream of the peripheral FXR-FGF15/19 pathway.","method":"Hepatic Fgf4 conditional knockout; FXR ChIP on Fgf4 promoter; FGFR4 inhibition; Cyp7a1/Cyp8b1 expression assays; cholestasis mouse models","journal":"Cell Metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO plus ChIP plus pharmacological inhibition of FGFR4 plus cholestasis model; multiple orthogonal methods in one study","pmids":["39393353"],"is_preprint":false},{"year":2004,"finding":"HST-1/FGF-4 protects male germ cells from heat-stress-induced apoptosis; adenoviral FGF-4 overexpression reduces germ cell TUNEL staining, prevents testicular weight loss and sperm count reduction, activates MAPK survival signaling in germ cells, and stimulates lactate production in Sertoli cells.","method":"Adenoviral HST-1/FGF-4 delivery to mouse testis; hyperthermia model; TUNEL assay; MAPK pathway analysis; lactate production assay","journal":"Experimental Cell Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function with mechanistic readouts (MAPK, lactate); single lab, multiple readouts","pmids":["14980503"],"is_preprint":false},{"year":1995,"finding":"Hst-1/FGF-4 antisense oligonucleotides block mouse limb development in an organ culture system, while sense and scrambled oligonucleotides have no effect, demonstrating that Hst-1/FGF-4 is required for limb outgrowth.","method":"Antisense oligodeoxynucleotide treatment of mouse limb bud explants in organ culture; limb morphology analysis","journal":"Journal of Cell Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — antisense loss-of-function with appropriate controls in organ culture; single lab","pmids":["7642715"],"is_preprint":false},{"year":2006,"finding":"FGF-4 regulates proliferation and neuronal differentiation of neural progenitor cells; recombinant FGF-4 promotes formation of large neurospheres with multipotent differentiation ability and significantly promotes neuronal differentiation in clonal neurosphere culture. Fgf-4 mRNA is expressed in postnatal mouse hippocampus, SVZ, and rostral migratory stream.","method":"In vitro neurosphere assay with recombinant FGF-4; in situ hybridization of Fgf-4 in brain; clonal neurosphere differentiation assay","journal":"FASEB Journal","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — in vitro gain-of-function with functional readout; single lab, single main method","pmids":["16723380"],"is_preprint":false},{"year":1990,"finding":"EC cell-specific expression of K-fgf/FGF4 is controlled by enhancer-like elements in the 3' noncoding region of exon 3 (downstream of the coding sequence), not by upstream promoter sequences; these elements promote expression in undifferentiated EC cells but not in differentiated or non-EC cells.","method":"CAT reporter transfections with 3' and 5' K-fgf regulatory element constructs; transfection into undifferentiated vs. differentiated F9 EC cells","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter deletion analysis with functional readout; single lab with systematic mapping","pmids":["2188089"],"is_preprint":false},{"year":1991,"finding":"The FGF4 gene (kFGF) is a target for positive transcriptional regulation by Oct4 via an octamer sequence in its distal enhancer; Oct4 but not Oct1 is bound in undifferentiated EC cells, while only Oct1 is present after differentiation.","method":"EMSA with nuclear extracts from undifferentiated and differentiated EC cells; reporter assays","journal":"Mechanisms of Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA with differentiation-state comparison plus reporter assay; single lab, consistent with PMID 7590241","pmids":["1723621"],"is_preprint":false},{"year":2017,"finding":"A highly expressed FGF4 retrogene on canine chromosome 12 (CFA12) is responsible for chondrodystrophy (shortened limbs) and intervertebral disc disease in dogs, with an odds ratio of 51.23 for IVDD, demonstrating that ectopic FGF4 expression causes skeletal dysplasia through FGF signaling pathway abnormalities.","method":"Genome-wide association study + whole genome sequencing; segregation analysis; copy number analysis; retrogene expression analysis","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — genetic mapping with strong association and expression evidence; mechanistic inference from retrogene expression, not direct functional experiment","pmids":["29073074"],"is_preprint":false}],"current_model":"FGF4 is a secreted, heparin-binding growth factor that signals through FGFR1–4 (with tissue-specific engagement gated by heparan sulfate sulfation patterns) to activate autocrine/paracrine mitogenic and survival pathways (RAS-MEK-ERK, AMPK, MAPK) in diverse cellular contexts: it is transcriptionally activated in pluripotent cells by a Sox2/Oct-3 ternary complex on a 3′ distal enhancer (with PARP1-mediated PARylation of Sox2 fine-tuning its activity), and functionally it maintains trophoblast stem cell self-renewal, drives FRS2α→Cdx2→Bmp4 paracrine signaling between ICM and trophectoderm, directs ICM lineage restriction to epiblast vs. primitive endoderm via ERK, acts as the AER wavefront signal (together with FGF8) for limb mesenchyme survival and somitogenesis, induces tendon marker expression and mesenchymal cell chemotaxis in the limb, regulates bile acid homeostasis via an FGFR4–LRH-1–CYP7A1 axis in the liver, and promotes platelet/megakaryocyte production and germ cell survival in vivo."},"narrative":{"mechanistic_narrative":"FGF4 is a secreted, heparin-binding growth factor (~18 kDa) that drives autocrine and paracrine mitogenic and survival signaling by engaging extracellular FGF receptors, and it functions as a master regulator of progenitor maintenance and lineage decisions across early development [PMID:2978866, PMID:1990270]. Its activity is gated by heparan sulfate: FGF4 requires a tissue-specific HS sulfation pattern distinct from FGF2, and FGFR2-IIIc binds FGF4/HS complexes broadly while FGFR1-IIIc largely does not, providing context-dependent receptor engagement [PMID:11724824]. FGF4 expression is itself restricted to pluripotent/undifferentiated cells through a 3' distal enhancer bound cooperatively by Sox2 and Oct-3/4, where only the Sox2/Oct-3 ternary complex activates transcription and PARP1-mediated PARylation of Sox2 tunes enhancer occupancy [PMID:7590241, PMID:2188089, PMID:1723621, PMID:19531481]. In the early embryo FGF4 maintains trophoblast stem cell self-renewal and supports inner cell mass proliferation, and it directs ICM lineage restriction toward epiblast versus primitive endoderm via ERK signaling, with a FRS2α→ERK→Cdx2→Bmp4 paracrine axis relaying the signal between trophectoderm and ICM [PMID:9851926, PMID:7809630, PMID:23193166, PMID:19890878]. In the developing limb FGF4 acts as an AER-derived signal redundant with FGF8 — single Fgf4 loss is dispensable, but combined Fgf4/Fgf8 loss abolishes limb mesenchyme survival, and FGF4 can fully substitute for FGF8 — while also promoting mesenchymal proliferation, chemotaxis, and somitogenesis/axial elongation by maintaining presomitic mesoderm and WNT activity [PMID:10802662, PMID:15328019, PMID:8421496, PMID:10395792, PMID:21368122, PMID:22954964]. In adult physiology FGF4 signals through FGFR4 to control hepatic bile acid homeostasis via an FXR→FGF4→FGFR4–LRH-1 axis repressing Cyp7a1/Cyp8b1, and protects the liver in NAFLD/NASH through a Ca2+/CaMKKβ–AMPK–Caspase 6 pathway [PMID:39393353, PMID:35152446]. Ectopic FGF4 expression from a canine retrogene causes chondrodystrophy and intervertebral disc disease, linking FGF4 dosage to skeletal dysplasia [PMID:29073074].","teleology":[{"year":1988,"claim":"Established the basic biochemical identity of FGF4 as a secreted mitogen, answering what kind of molecule the hst-1 transforming gene encodes.","evidence":"Baculovirus expression, heparin-affinity purification, mitogenesis and soft-agar assays","pmids":["2978866"],"confidence":"High","gaps":["Receptor identity not defined","No physiological source tissue identified"]},{"year":1991,"claim":"Showed FGF4 transforms cells specifically through secretion and extracellular receptor engagement, distinguishing an autocrine extracellular mechanism from intracellular action.","evidence":"Signal-peptide deletion and KDEL retention mutants, neutralizing antibody reversal in soft-agar assays; receptor binding/suramin in NIH3T3","pmids":["1990270","2553749"],"confidence":"High","gaps":["Specific FGFR engaged not resolved","HS dependence not yet defined"]},{"year":1995,"claim":"Defined the transcriptional logic restricting FGF4 to pluripotent cells, identifying Sox2/Oct-3 cooperative enhancer binding as the activating mechanism.","evidence":"EMSA, reporter assays and mutagenesis in EC cells; earlier 3' enhancer mapping and Oct4 binding studies","pmids":["7590241","2188089","1723621"],"confidence":"High","gaps":["Did not address post-translational modulation of the complex","Did not connect to downstream signaling outcomes"]},{"year":1995,"claim":"Established FGF4 as essential for postimplantation development by genetic ablation, showing it is required for ICM proliferation.","evidence":"Knockout mouse with embryo culture and FGF4 protein rescue","pmids":["7809630"],"confidence":"High","gaps":["Receptor and downstream pathway in ICM not defined","Lineage-specification role not yet separated from proliferation"]},{"year":1998,"claim":"Identified FGF4 as the required niche signal sustaining trophoblast stem cell self-renewal, answering what maintains the undifferentiated TS state.","evidence":"TS cell culture with/without FGF4 plus in vivo chimera assay","pmids":["9851926"],"confidence":"High","gaps":["Intracellular signaling cascade not mapped","Source/receptor topology not defined"]},{"year":2004,"claim":"Resolved FGF4/FGF8 redundancy in the limb, showing FGF4 can fully substitute for FGF8 and that combined AER-FGF activity is required for mesenchyme survival.","evidence":"Conditional allele swap and double conditional knockout with skeletal/molecular analysis; earlier conditional Fgf4 KO showing dispensability alone","pmids":["15328019","10802662"],"confidence":"High","gaps":["Quantitative contribution of each FGF not separated","Receptor usage in mesenchyme not defined"]},{"year":2010,"claim":"Mapped the paracrine signaling order from FGF4 to Bmp4, establishing FGF4→FRS2α→ERK→Cdx2→Bmp4 as the trophectoderm-to-ICM relay.","evidence":"FRS2α KO cells, ERK assays, Cdx2 ChIP on Bmp4 promoter, Bmp4 rescue of Frs2α-null ICM","pmids":["19890878"],"confidence":"High","gaps":["Receptor identity upstream of FRS2α not specified","Generalizability beyond TS/ICM not tested"]},{"year":2012,"claim":"Clarified that FGF4/ERK controls lineage bias acquisition rather than initial marker activation in the ICM, refining its role in EPI vs PrE segregation.","evidence":"Zygotic and maternal/zygotic Fgf4 conditional KO with NANOG/GATA6 immunofluorescence and FGF rescue; parallel PSM and axial-elongation double-KO studies","pmids":["23193166","21368122","22954964"],"confidence":"High","gaps":["Single-cell dynamics of salt-and-pepper resolution not fully resolved","FGF4 vs FGF8 contributions in PSM not individually dissected"]},{"year":2013,"claim":"Connected enhancer regulation to PARP1, showing PARylation of Sox2 tunes FGF4 expression and reprogramming efficiency.","evidence":"ChIP, in vitro PARylation, Artd1-/- reprogramming with FGF4 rescue","pmids":["19531481","23939864"],"confidence":"High","gaps":["Stoichiometry/sites of Sox2 PARylation in vivo not fully defined","Whether this applies to all FGF4-expressing contexts unknown"]},{"year":2024,"claim":"Defined an adult metabolic role for FGF4 in the liver, establishing an FXR→FGF4→FGFR4–LRH-1 checkpoint for bile acid homeostasis and an AMPK-dependent hepatoprotective axis.","evidence":"Hepatic Fgf4 conditional KO, FXR ChIP, FGFR4 inhibition, Cyp7a1/Cyp8b1 assays, cholestasis and NAFLD/NASH models","pmids":["39393353","35152446"],"confidence":"High","gaps":["Crosstalk with peripheral FGF15/19 quantitatively unresolved","Human relevance of hepatic FGF4 axis not established in timeline"]},{"year":null,"claim":"How a single ligand achieves its many distinct outcomes — the precise FGFR/HS combinations and receptor-proximal signaling that distinguish proliferation, survival, chemotaxis, lineage bias, and metabolic checkpoint functions in each tissue — remains unresolved.","evidence":"No single discovery in the timeline integrates the receptor/HS code with the divergent cellular outputs","pmids":[],"confidence":"Low","gaps":["No unified receptor-output map across tissues","Structural basis of HS-pattern selectivity not determined","Human disease relevance largely inferred from model organisms and canine retrogene"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[10,11,13]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[13]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[12,21,31]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[10,11]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[21,28,31]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,6,8,7]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[32,31]}],"complexes":[],"partners":["FGFR2","FGFR1","FGFR4","FGFR3","FRS2","LRH-1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P08620","full_name":"Fibroblast growth factor 4","aliases":["Heparin secretory-transforming protein 1","HST","HST-1","HSTF-1","Heparin-binding growth factor 4","HBGF-4","Transforming protein KS3"],"length_aa":206,"mass_kda":22.0,"function":"Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal limb and cardiac valve development during embryogenesis. May play a role in embryonic molar tooth bud development via inducing the expression of MSX1, MSX2 and MSX1-mediated expression of SDC1 in dental mesenchyme cells (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P08620/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FGF4","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FGF4","total_profiled":1310},"omim":[{"mim_id":"621260","title":"SHORT-RIB THORACIC DYSPLASIA 22 WITHOUT POLYDACTYLY; SRTD22","url":"https://www.omim.org/entry/621260"},{"mim_id":"619640","title":"LYSINE DEMETHYLASE 7A; KDM7A","url":"https://www.omim.org/entry/619640"},{"mim_id":"615719","title":"TCL1 UPSTREAM NEURAL DIFFERENTIATION-ASSOCIATED RNA; TUNAR","url":"https://www.omim.org/entry/615719"},{"mim_id":"611539","title":"FORKHEAD BOX D3; FOXD3","url":"https://www.omim.org/entry/611539"},{"mim_id":"609675","title":"SCLEROSTIN DOMAIN-CONTAINING PROTEIN 1; SOSTDC1","url":"https://www.omim.org/entry/609675"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/FGF4"},"hgnc":{"alias_symbol":["K-FGF","HBGF-4","HST","HST-1","KFGF"],"prev_symbol":["HSTF1"]},"alphafold":{"accession":"P08620","domains":[{"cath_id":"2.80.10.50","chopping":"81-204","consensus_level":"high","plddt":97.2406,"start":81,"end":204}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P08620","model_url":"https://alphafold.ebi.ac.uk/files/AF-P08620-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P08620-F1-predicted_aligned_error_v6.png","plddt_mean":81.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FGF4","jax_strain_url":"https://www.jax.org/strain/search?query=FGF4"},"sequence":{"accession":"P08620","fasta_url":"https://rest.uniprot.org/uniprotkb/P08620.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P08620/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P08620"}},"corpus_meta":[{"pmid":"9851926","id":"PMC_9851926","title":"Promotion of trophoblast stem cell proliferation by FGF4.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9851926","citation_count":1139,"is_preprint":false},{"pmid":"1618140","id":"PMC_1618140","title":"Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1618140","citation_count":621,"is_preprint":false},{"pmid":"7590241","id":"PMC_7590241","title":"Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7590241","citation_count":611,"is_preprint":false},{"pmid":"7809630","id":"PMC_7809630","title":"Requirement of FGF-4 for postimplantation mouse development.","date":"1995","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/7809630","citation_count":606,"is_preprint":false},{"pmid":"10524628","id":"PMC_10524628","title":"Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10524628","citation_count":378,"is_preprint":false},{"pmid":"8421496","id":"PMC_8421496","title":"FGF-4 and BMP-2 have opposite effects on limb growth.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8421496","citation_count":358,"is_preprint":false},{"pmid":"2649847","id":"PMC_2649847","title":"Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family.","date":"1989","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2649847","citation_count":318,"is_preprint":false},{"pmid":"2959959","id":"PMC_2959959","title":"Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein.","date":"1987","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2959959","citation_count":297,"is_preprint":false},{"pmid":"10802662","id":"PMC_10802662","title":"Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10802662","citation_count":242,"is_preprint":false},{"pmid":"23193166","id":"PMC_23193166","title":"FGF4 is required for lineage restriction and salt-and-pepper distribution of primitive endoderm factors but not their initial expression in the mouse.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23193166","citation_count":220,"is_preprint":false},{"pmid":"11180951","id":"PMC_11180951","title":"Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11180951","citation_count":215,"is_preprint":false},{"pmid":"12502739","id":"PMC_12502739","title":"FGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1(-/-) mice.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12502739","citation_count":206,"is_preprint":false},{"pmid":"9927596","id":"PMC_9927596","title":"Sequential roles for Fgf4, En1 and Fgf8 in specification and regionalisation of the midbrain.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9927596","citation_count":181,"is_preprint":false},{"pmid":"1706218","id":"PMC_1706218","title":"Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors.","date":"1991","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/1706218","citation_count":179,"is_preprint":false},{"pmid":"2529025","id":"PMC_2529025","title":"High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.","date":"1989","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/2529025","citation_count":178,"is_preprint":false},{"pmid":"2548184","id":"PMC_2548184","title":"The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2548184","citation_count":173,"is_preprint":false},{"pmid":"15328019","id":"PMC_15328019","title":"The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15328019","citation_count":159,"is_preprint":false},{"pmid":"2483371","id":"PMC_2483371","title":"Mesoderm-inducing properties of INT-2 and kFGF: two oncogene-encoded growth factors related to FGF.","date":"1989","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2483371","citation_count":156,"is_preprint":false},{"pmid":"7925026","id":"PMC_7925026","title":"Expression and function of FGF-4 in peri-implantation development in mouse embryos.","date":"1994","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7925026","citation_count":153,"is_preprint":false},{"pmid":"12086472","id":"PMC_12086472","title":"Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12086472","citation_count":146,"is_preprint":false},{"pmid":"2553749","id":"PMC_2553749","title":"Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.","date":"1989","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/2553749","citation_count":144,"is_preprint":false},{"pmid":"21368122","id":"PMC_21368122","title":"FGF4 and FGF8 comprise the wavefront activity that controls somitogenesis.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21368122","citation_count":143,"is_preprint":false},{"pmid":"8380647","id":"PMC_8380647","title":"Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8380647","citation_count":130,"is_preprint":false},{"pmid":"22890726","id":"PMC_22890726","title":"FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.","date":"2013","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/22890726","citation_count":127,"is_preprint":false},{"pmid":"11923208","id":"PMC_11923208","title":"Early embryonic expression of FGF4/6/9 gene and its role in the induction of mesenchyme and notochord in Ciona savignyi embryos.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11923208","citation_count":126,"is_preprint":false},{"pmid":"11724824","id":"PMC_11724824","title":"Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11724824","citation_count":124,"is_preprint":false},{"pmid":"29073074","id":"PMC_29073074","title":"FGF4 retrogene on CFA12 is responsible for chondrodystrophy and intervertebral disc disease in dogs.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29073074","citation_count":114,"is_preprint":false},{"pmid":"32883967","id":"PMC_32883967","title":"In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32883967","citation_count":108,"is_preprint":false},{"pmid":"9441693","id":"PMC_9441693","title":"Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny.","date":"1997","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9441693","citation_count":105,"is_preprint":false},{"pmid":"22954964","id":"PMC_22954964","title":"Signaling by FGF4 and FGF8 is required for axial elongation of the mouse embryo.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22954964","citation_count":96,"is_preprint":false},{"pmid":"19277121","id":"PMC_19277121","title":"FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19277121","citation_count":86,"is_preprint":false},{"pmid":"2188089","id":"PMC_2188089","title":"Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2188089","citation_count":86,"is_preprint":false},{"pmid":"10395792","id":"PMC_10395792","title":"Cell migration and chick limb development: chemotactic action of FGF-4 and the AER.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10395792","citation_count":86,"is_preprint":false},{"pmid":"16308330","id":"PMC_16308330","title":"Increasing Fgf4 expression in the mouse limb bud causes polysyndactyly and rescues the skeletal defects that result from loss of Fgf8 function.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16308330","citation_count":81,"is_preprint":false},{"pmid":"3133332","id":"PMC_3133332","title":"Coamplification of the hst-1 and int-2 genes in human cancers.","date":"1988","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/3133332","citation_count":79,"is_preprint":false},{"pmid":"2608276","id":"PMC_2608276","title":"Transformation by basic fibroblast growth factor requires high levels of expression: comparison with transformation by hst/K-fgf.","date":"1989","source":"Oncogene research","url":"https://pubmed.ncbi.nlm.nih.gov/2608276","citation_count":79,"is_preprint":false},{"pmid":"2856253","id":"PMC_2856253","title":"Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma.","date":"1988","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2856253","citation_count":75,"is_preprint":false},{"pmid":"35870977","id":"PMC_35870977","title":"Exosomes from mmu_circ_0001052-modified adipose-derived stem cells promote angiogenesis of DFU via miR-106a-5p and FGF4/p38MAPK pathway.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35870977","citation_count":72,"is_preprint":false},{"pmid":"1423296","id":"PMC_1423296","title":"Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.","date":"1992","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/1423296","citation_count":72,"is_preprint":false},{"pmid":"2780052","id":"PMC_2780052","title":"Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells.","date":"1989","source":"Oncogene research","url":"https://pubmed.ncbi.nlm.nih.gov/2780052","citation_count":69,"is_preprint":false},{"pmid":"10415361","id":"PMC_10415361","title":"Expression of Fgf4 during early development of the chick embryo.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10415361","citation_count":67,"is_preprint":false},{"pmid":"16804893","id":"PMC_16804893","title":"FGF-4 signaling is involved in mir-206 expression in developing somites of chicken embryos.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16804893","citation_count":65,"is_preprint":false},{"pmid":"7506139","id":"PMC_7506139","title":"FGF-4 regulates expression of Evx-1 in the developing mouse limb.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7506139","citation_count":64,"is_preprint":false},{"pmid":"15671174","id":"PMC_15671174","title":"Heparan 2-O-sulfotransferase, hst-2, is essential for normal cell migration in Caenorhabditis elegans.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15671174","citation_count":63,"is_preprint":false},{"pmid":"19531481","id":"PMC_19531481","title":"PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19531481","citation_count":62,"is_preprint":false},{"pmid":"35152446","id":"PMC_35152446","title":"FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis.","date":"2022","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/35152446","citation_count":55,"is_preprint":false},{"pmid":"14688221","id":"PMC_14688221","title":"Immunolocalization of BMP-2/-4, FGF-4, and WNT10b in the developing mouse first lower molar.","date":"2004","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/14688221","citation_count":55,"is_preprint":false},{"pmid":"21215265","id":"PMC_21215265","title":"FGF4-dependent stem cells derived from rat blastocysts differentiate along the trophoblast lineage.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21215265","citation_count":55,"is_preprint":false},{"pmid":"25329002","id":"PMC_25329002","title":"Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.","date":"2014","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25329002","citation_count":54,"is_preprint":false},{"pmid":"2272506","id":"PMC_2272506","title":"Hst-3: an X-linked hybrid sterility gene.","date":"1990","source":"Genetical research","url":"https://pubmed.ncbi.nlm.nih.gov/2272506","citation_count":54,"is_preprint":false},{"pmid":"7601570","id":"PMC_7601570","title":"Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells.","date":"1995","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7601570","citation_count":53,"is_preprint":false},{"pmid":"2740210","id":"PMC_2740210","title":"The mouse homologue of hst/k-FGF: sequence, genome organization and location relative to int-2.","date":"1989","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2740210","citation_count":53,"is_preprint":false},{"pmid":"39393353","id":"PMC_39393353","title":"Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress.","date":"2024","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/39393353","citation_count":52,"is_preprint":false},{"pmid":"24445281","id":"PMC_24445281","title":"Paracrine effects of embryo-derived FGF4 and BMP4 during pig trophoblast elongation.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24445281","citation_count":52,"is_preprint":false},{"pmid":"16723380","id":"PMC_16723380","title":"FGF-4 regulates neural progenitor cell proliferation and neuronal differentiation.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/16723380","citation_count":51,"is_preprint":false},{"pmid":"1990270","id":"PMC_1990270","title":"The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway.","date":"1991","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1990270","citation_count":50,"is_preprint":false},{"pmid":"8550832","id":"PMC_8550832","title":"Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription.","date":"1996","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8550832","citation_count":49,"is_preprint":false},{"pmid":"1723621","id":"PMC_1723621","title":"Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells.","date":"1991","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/1723621","citation_count":48,"is_preprint":false},{"pmid":"3136110","id":"PMC_3136110","title":"Amplification of the hst-1 gene in human esophageal carcinomas.","date":"1988","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/3136110","citation_count":48,"is_preprint":false},{"pmid":"2481673","id":"PMC_2481673","title":"Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells.","date":"1989","source":"In vitro cellular & developmental biology : journal of the Tissue Culture Association","url":"https://pubmed.ncbi.nlm.nih.gov/2481673","citation_count":46,"is_preprint":false},{"pmid":"11319857","id":"PMC_11319857","title":"Misexpression of Fgf-4 in the chick limb inhibits myogenesis by down-regulating Frek expression.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11319857","citation_count":46,"is_preprint":false},{"pmid":"19890878","id":"PMC_19890878","title":"An FGF4-FRS2alpha-Cdx2 axis in trophoblast stem cells induces Bmp4 to regulate proper growth of early mouse embryos.","date":"2010","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/19890878","citation_count":46,"is_preprint":false},{"pmid":"2978866","id":"PMC_2978866","title":"hst-1 transforming protein: expression in silkworm cells and characterization as a novel heparin-binding growth factor.","date":"1988","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2978866","citation_count":45,"is_preprint":false},{"pmid":"27677589","id":"PMC_27677589","title":"FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27677589","citation_count":44,"is_preprint":false},{"pmid":"18792115","id":"PMC_18792115","title":"Pleiotropic function of FGF-4: its role in development and stem cells.","date":"2009","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18792115","citation_count":43,"is_preprint":false},{"pmid":"2895649","id":"PMC_2895649","title":"Cloned hst gene from normal human leukocyte DNA transforms NIH3T3 cells.","date":"1988","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2895649","citation_count":43,"is_preprint":false},{"pmid":"21649665","id":"PMC_21649665","title":"TGF-β1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma.","date":"2011","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/21649665","citation_count":42,"is_preprint":false},{"pmid":"17852409","id":"PMC_17852409","title":"FGF-4 increases in vitro expansion rate of human adult bone marrow-derived mesenchymal stem cells.","date":"2007","source":"Growth factors (Chur, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/17852409","citation_count":41,"is_preprint":false},{"pmid":"1537072","id":"PMC_1537072","title":"In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line.","date":"1992","source":"Cancer chemotherapy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1537072","citation_count":41,"is_preprint":false},{"pmid":"7999365","id":"PMC_7999365","title":"Function of FGF-4 in limb development.","date":"1994","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/7999365","citation_count":38,"is_preprint":false},{"pmid":"11222686","id":"PMC_11222686","title":"Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.","date":"2001","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11222686","citation_count":36,"is_preprint":false},{"pmid":"9740330","id":"PMC_9740330","title":"Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer.","date":"1998","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/9740330","citation_count":36,"is_preprint":false},{"pmid":"25515008","id":"PMC_25515008","title":"Establishment of a primed pluripotent epiblast stem cell in FGF4-based conditions.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25515008","citation_count":35,"is_preprint":false},{"pmid":"8621231","id":"PMC_8621231","title":"Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.","date":"1996","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8621231","citation_count":35,"is_preprint":false},{"pmid":"19481538","id":"PMC_19481538","title":"Fgf4 is required for left-right patterning of visceral organs in zebrafish.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19481538","citation_count":34,"is_preprint":false},{"pmid":"9509064","id":"PMC_9509064","title":"Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.","date":"1998","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9509064","citation_count":34,"is_preprint":false},{"pmid":"8608216","id":"PMC_8608216","title":"Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8608216","citation_count":33,"is_preprint":false},{"pmid":"3060803","id":"PMC_3060803","title":"The FGF-related oncogene, K-FGF, maps to human chromosome region 11q13, possibly near int-2.","date":"1988","source":"Oncogene research","url":"https://pubmed.ncbi.nlm.nih.gov/3060803","citation_count":32,"is_preprint":false},{"pmid":"34651174","id":"PMC_34651174","title":"Cell-cell communication through FGF4 generates and maintains robust proportions of differentiated cell types in embryonic stem cells.","date":"2021","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34651174","citation_count":31,"is_preprint":false},{"pmid":"36702076","id":"PMC_36702076","title":"FGF4 improves hepatocytes ferroptosis in autoimmune hepatitis mice via activation of CISD3.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36702076","citation_count":31,"is_preprint":false},{"pmid":"7520355","id":"PMC_7520355","title":"Angiogenic activity of the recombinant hst-1 protein.","date":"1994","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/7520355","citation_count":31,"is_preprint":false},{"pmid":"25685159","id":"PMC_25685159","title":"Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice.","date":"2015","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/25685159","citation_count":31,"is_preprint":false},{"pmid":"7809043","id":"PMC_7809043","title":"Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7809043","citation_count":29,"is_preprint":false},{"pmid":"23939864","id":"PMC_23939864","title":"Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.","date":"2013","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/23939864","citation_count":29,"is_preprint":false},{"pmid":"9798677","id":"PMC_9798677","title":"FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9798677","citation_count":28,"is_preprint":false},{"pmid":"24535868","id":"PMC_24535868","title":"FGF4 and HGF promote differentiation of mouse bone marrow mesenchymal stem cells into hepatocytes via the MAPK pathway.","date":"2014","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/24535868","citation_count":28,"is_preprint":false},{"pmid":"1549352","id":"PMC_1549352","title":"Human hst-2 (FGF-6) oncogene: cDNA cloning and characterization.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1549352","citation_count":28,"is_preprint":false},{"pmid":"7763013","id":"PMC_7763013","title":"Sequence-dependent modulation of anticancer drug activities by 7-ethyl-10-hydroxycamptothecin in an HST-1 human squamous carcinoma cell line.","date":"1995","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7763013","citation_count":28,"is_preprint":false},{"pmid":"14980503","id":"PMC_14980503","title":"HST-1/FGF-4 protects male germ cells from apoptosis under heat-stress condition.","date":"2004","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/14980503","citation_count":27,"is_preprint":false},{"pmid":"9715278","id":"PMC_9715278","title":"FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9715278","citation_count":27,"is_preprint":false},{"pmid":"7635948","id":"PMC_7635948","title":"Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of HST-1 (FGF-4) gene.","date":"1995","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/7635948","citation_count":27,"is_preprint":false},{"pmid":"7642715","id":"PMC_7642715","title":"Hst-1 (FGF-4) antisense oligonucleotides block murine limb development.","date":"1995","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7642715","citation_count":26,"is_preprint":false},{"pmid":"30887595","id":"PMC_30887595","title":"Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.","date":"2019","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30887595","citation_count":26,"is_preprint":false},{"pmid":"10786811","id":"PMC_10786811","title":"FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma.","date":"2000","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/10786811","citation_count":26,"is_preprint":false},{"pmid":"26230325","id":"PMC_26230325","title":"Intestinal Commitment and Maturation of Human Pluripotent Stem Cells Is Independent of Exogenous FGF4 and R-spondin1.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26230325","citation_count":26,"is_preprint":false},{"pmid":"11764380","id":"PMC_11764380","title":"Predominant expression of fibroblast growth factor (FGF) 8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative components of testicular germ cell tumors.","date":"2001","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11764380","citation_count":25,"is_preprint":false},{"pmid":"19777059","id":"PMC_19777059","title":"FGF4 independent derivation of trophoblast stem cells from the common vole.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19777059","citation_count":25,"is_preprint":false},{"pmid":"11840335","id":"PMC_11840335","title":"HST-1/FGF-4 gene activation induces spermatogenesis and prevents adriamycin-induced testicular toxicity.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11840335","citation_count":23,"is_preprint":false},{"pmid":"29249667","id":"PMC_29249667","title":"O-GlcNAc on PKCζ Inhibits the FGF4-PKCζ-MEK-ERK1/2 Pathway via Inhibition of PKCζ Phosphorylation in Mouse Embryonic Stem Cells.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29249667","citation_count":23,"is_preprint":false},{"pmid":"8143931","id":"PMC_8143931","title":"All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas.","date":"1994","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/8143931","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48268,"output_tokens":9388,"usd":0.142812,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19320,"output_tokens":3744,"usd":0.0951,"stage2_stop_reason":"end_turn"},"total_usd":0.237912,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"FGF4 promotes proliferation of trophoblast stem cells; in the absence of FGF4, trophoblast stem cell lines differentiate to other trophoblast subtypes in vitro, establishing FGF4 as a required maintenance signal for trophoblast stem cell self-renewal.\",\n      \"method\": \"Trophoblast stem cell culture with/without FGF4; in vivo chimera assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO rescue experiments plus stem cell culture with defined phenotypic readouts, replicated across multiple labs\",\n      \"pmids\": [\"9851926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"FGF-4 gene expression requires synergistic action of Sox2 and Oct-3 binding to adjacent sites on the FGF-4 enhancer; Sox2 forms a ternary complex with either Oct-1 or Oct-3 on the enhancer DNA, but only the Sox2/Oct-3 complex drives transcriptional activation, identifying FGF4 as the first known target gene for Oct-3 and Sox factors.\",\n      \"method\": \"cDNA cloning, gel-shift (EMSA), transcriptional reporter assays, transfection into EC cells\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods (EMSA, reporter assays, mutagenesis) in one rigorous study; widely replicated\",\n      \"pmids\": [\"7590241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"FGF-4 is required for postimplantation mouse development; Fgf4-null embryos fail to proliferate the inner cell mass after implantation, and this proliferative defect is rescued by exogenous FGF-4 protein in culture.\",\n      \"method\": \"Gene targeting (knockout mouse), embryo culture with FGF-4 rescue\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined cellular phenotype plus protein rescue; replicated by subsequent studies\",\n      \"pmids\": [\"7809630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"FGF-4 protein stimulates proliferation of limb bud mesenchyme (pro-outgrowth), while BMP-2 inhibits limb growth; the extent of limb outgrowth can be modulated by mixing the two signals, demonstrating that limb growth is regulated by a balance of AER-derived stimulatory (FGF-4) and inhibitory (BMP-2) signals.\",\n      \"method\": \"In vitro limb bud culture system with FGF-4 and BMP-2 protein addition\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct in vitro functional assay with dose-response mixing experiment; replicated by multiple studies\",\n      \"pmids\": [\"8421496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FGF4 signaling from the posterior AER maintains the polarizing region (SHH/FGF4 feedback loop); the BMP antagonist Gremlin relays the SHH signal from the polarizing region to the AER to induce Fgf4 expression; Gremlin-expressing cell grafts rescue Fgf4 expression and restore the feedback loop in limb deformity mutants.\",\n      \"method\": \"Genetic analysis of Shh-null and limb deformity mutant embryos; cell grafting experiments; in situ hybridization\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in multiple mutant backgrounds plus rescue by cell grafting; two orthogonal approaches\",\n      \"pmids\": [\"10524628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Conditional inactivation of Fgf4 alone in mouse limbs does not disrupt Shh expression or limb formation, contradicting the SHH/FGF4 feedback loop model; instead, Fgf9 and Fgf17 (but not Fgf8) expression in the AER is dependent on Shh, indicating that combined AER-FGF activities—not FGF4 alone—maintain the feedback loop with Shh.\",\n      \"method\": \"Conditional gene targeting (Cre/lox) of Fgf4 in AER; in situ hybridization of downstream targets\",\n      \"journal\": \"Nature Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with in situ readouts; directly contradicts prior model and is a rigorous negative result\",\n      \"pmids\": [\"10802662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"FGF4 can functionally replace FGF8 in limb skeletal development; when Fgf4 is expressed in place of Fgf8 via conditional allele swap, all skeletal defects caused by Fgf8 loss are rescued. Simultaneous loss of both Fgf4 and Fgf8 in the AER causes failure of limb bud mesenchyme survival, with nearly abolished Shh and Fgf10 expression.\",\n      \"method\": \"Conditional Cre-mediated allele swap (Fgf4 gain-of-function + Fgf8 loss-of-function); double conditional knockout; skeletal analysis\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional allele replacement plus double KO with defined skeletal and molecular phenotypes; two orthogonal approaches\",\n      \"pmids\": [\"15328019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FGF4 is required for lineage restriction of primitive endoderm (PrE) in the blastocyst ICM; Fgf4-null ICMs initiate co-expression of EPI and PrE markers but fail to achieve salt-and-pepper segregation and exclusive NANOG or GATA6 expression, establishing FGF4/ERK signaling as the mechanism for lineage bias acquisition rather than initial lineage marker activation.\",\n      \"method\": \"Zygotic and maternal/zygotic Fgf4 conditional knockout; immunofluorescence for NANOG/GATA6; exogenous FGF rescue experiments\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with quantitative immunofluorescence phenotyping plus rescue; multiple alleles tested\",\n      \"pmids\": [\"23193166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FGF4 and FGF8 together constitute the wavefront signal that maintains presomitic mesoderm (PSM) in an undifferentiated state during somitogenesis; double deletion of Fgf4 and Fgf8 in the PSM abolishes expression of cycling genes, WNT pathway genes, and PSM progenitor markers, causing premature differentiation of the entire PSM. FGF signaling maintains WNT signaling and operates independently of WNT in parallel.\",\n      \"method\": \"Double conditional Fgf4/Fgf8 knockout in PSM; in situ hybridization; WNT pathway rescue experiments\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double conditional KO with molecular phenotyping and genetic epistasis with WNT pathway; multiple orthogonal readouts\",\n      \"pmids\": [\"21368122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FGF4 and FGF8 signaling are required for axial elongation after gastrulation; combined loss of Fgf8 and Fgf4 during late gastrulation causes severe vertebral phenotype and failure to maintain epiblast progenitors that generate paraxial mesoderm, with reduced Wnt3a, Brachyury, and NOTCH pathway gene expression.\",\n      \"method\": \"Double conditional knockout; skeletal analysis; gene expression analysis\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double conditional KO with skeletal and molecular phenotypes; two orthogonal methods\",\n      \"pmids\": [\"22954964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The hst-1 (FGF4) transforming protein, expressed in insect cells, is a secreted heparin-binding growth factor of ~18 kDa that stimulates DNA synthesis in NIH3T3 cells and endothelial cell proliferation, and induces anchorage-independent growth.\",\n      \"method\": \"Baculovirus expression in BmN cells; heparin-affinity purification; mitogenesis assay; soft agar assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — protein purification and direct biochemical characterization; replicated by subsequent studies\",\n      \"pmids\": [\"2978866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"K-fgf/hst transformation of NIH 3T3 cells occurs via an autocrine mechanism requiring extracellular receptor activation; deletion of the signal peptide or retention of K-FGF in the ER/Golgi markedly reduces focus-forming ability, and anti-K-FGF neutralizing antibodies reverse the transformed phenotype, demonstrating that secretion and extracellular receptor engagement are required.\",\n      \"method\": \"Signal peptide deletion mutants; KDEL retention mutant; neutralizing antibody reversal; soft agar growth assay\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of secretory pathway signals plus antibody neutralization; multiple orthogonal methods in one study\",\n      \"pmids\": [\"1990270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"NIH 3T3 cells transformed by hst/K-fgf show downregulation of FGF receptors, and this transformation is reversed by suramin (which blocks FGF-receptor interaction), indicating that K-FGF transforms cells through autocrine activation of its receptor and that K-FGF and bFGF may share the same receptor.\",\n      \"method\": \"125I-bFGF receptor binding assay; suramin treatment; focus formation and transformation assays\",\n      \"journal\": \"Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor binding assay plus pharmacological reversal plus comparison with control oncogene; two orthogonal methods\",\n      \"pmids\": [\"2553749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FGF-4 binds heparan sulfate (HS) in a tissue-specific manner requiring a distinct HS sulfation pattern different from FGF-2; FGF-4 fails to bind HS or activate signaling in vascular tissues. FGFR2-IIIc binds all FGF-4/HS complexes, but FGFR1-IIIc fails to bind FGF-4/HS in most tissues, establishing that tissue-specific HS sulfation patterns differentially control FGF-4 signaling.\",\n      \"method\": \"FGF-4 and FGFR ectodomain probing of embryonic tissue sections; BaF3 cell proliferation assays with FR1c or FR2c\",\n      \"journal\": \"Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct tissue-binding and cell-based functional assays with ectodomain constructs; two orthogonal approaches\",\n      \"pmids\": [\"11724824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PARP1 binds the FGF4 enhancer, positively regulates FGF4 expression, and poly(ADP-ribosyl)ates Sox2, promoting dissociation/degradation of inhibitory Sox2 from the FGF4 enhancer; inhibition of PARP1 increases Sox2 occupancy at the FGF4 enhancer and reduces FGF4 expression, while Sox2 knockdown abrogates the inhibitory effect of PARP1 inhibitors on FGF4.\",\n      \"method\": \"ChIP on FGF4 enhancer; Co-IP of PARP1 with Oct4/Sox2; in vitro poly(ADP-ribosyl)ation assay; siRNA knockdown; PARP1 inhibitor treatment\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — biochemical PTM assay plus ChIP plus genetic rescue; multiple orthogonal methods in one study\",\n      \"pmids\": [\"19531481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PARP1/ARTD1-mediated poly(ADP-ribosyl)ation (PARylation) of Sox2 promotes Sox2 binding to the Fgf4 enhancer and activates Fgf4 expression during early reprogramming; Artd1-deficient fibroblasts show strongly decreased reprogramming capacity, and exogenous FGF4 (days 2–4) restores reprogramming efficiency in Artd1-null cells.\",\n      \"method\": \"Artd1-/- fibroblast reprogramming; Fgf4 reporter assays; FGF4 rescue experiment; ChIP\",\n      \"journal\": \"Stem Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with phenotype plus FGF4 rescue plus ChIP; multiple orthogonal methods replicating PMID 19531481\",\n      \"pmids\": [\"23939864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"FGF-4 can induce Evx-1 (a homeobox gene normally regulated by AER signals) expression in limb bud mesenchyme; this induction is indirect (blocked by protein synthesis inhibitor) and is modulated by BMP-2, positioning Evx-1 as a downstream target in the FGF-4 signal transduction pathway in the limb.\",\n      \"method\": \"In vitro limb bud culture; cycloheximide (protein synthesis inhibitor) block; BMP-2 co-treatment\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional in vitro culture with pharmacological inhibition; single lab, two orthogonal approaches\",\n      \"pmids\": [\"7506139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"FGF-4 protein can substitute for the AER to allow virtually normal limb outgrowth and patterning after AER removal in chick limb; FGF-4 stimulates proliferation of limb mesenchyme and maintains polarizing region activity.\",\n      \"method\": \"AER removal + FGF-4 protein bead implant in ovo; DiI cell labeling; skeletal analysis\",\n      \"journal\": \"Molecular Reproduction and Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo rescue assay with protein beads; single lab with defined phenotypic readout\",\n      \"pmids\": [\"7999365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FGF-4 acts as a potent chemoattractive agent for limb bud mesenchymal cells in a dose-dependent manner; this chemotactic activity is independent of FGF-4's ability to induce Shh expression. The AER exerts chemoattractive function on subapical cells during limb outgrowth, partly mediated by FGF-4 production.\",\n      \"method\": \"DiI cell labeling + FGF-4 bead implantation; partial AER removal; cell migration tracking\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cell migration assay with dose-response and AER removal; single lab\",\n      \"pmids\": [\"10395792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FGFR2-IIIb acts upstream of Shh and Fgf4 in the limb; Fgfr2-IIIb knockout mice lack Shh and Fgf4 expression in limb buds despite normal Fgf8, Fgf10, Bmp4, and Msx1, placing Shh and Fgf4 induction as downstream targets of FGFR2-IIIb signaling.\",\n      \"method\": \"Fgfr2-IIIb knockout mouse; in situ hybridization for downstream targets\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with in situ hybridization of multiple downstream targets; single lab but clean epistasis\",\n      \"pmids\": [\"11180951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FGF4 is a direct transcriptional target of LEF1/Wnt signaling; FGF4 beads fully rescue developmental arrest of Lef1-null tooth germs, and FGF4 induces Fgf3 in dental mesenchyme and subsequently Shh in epithelium, establishing an FGF4-dependent signal relay cascade in tooth development.\",\n      \"method\": \"LEF1 knockout analysis; FGF4 protein bead rescue in Lef1-/- tooth germs; LEF1 ChIP/reporter assay; in situ hybridization for downstream targets\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic rescue plus direct target identification plus signaling cascade analysis; multiple orthogonal methods\",\n      \"pmids\": [\"12502739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"FGF4 signaling through FRS2α activates ERK and enhances Cdx2 expression in trophoblast stem cells; Cdx2 then binds an FGF4-responsive enhancer in the Bmp4 promoter to drive Bmp4 production; exogenous Bmp4 rescues defective growth of Frs2α-null ICM, establishing an FGF4→FRS2α→ERK→Cdx2→Bmp4 paracrine axis between trophectoderm and ICM.\",\n      \"method\": \"FRS2α knockout ESC/TS cells; ERK activation assay; Cdx2 ChIP on Bmp4 promoter; Bmp4 rescue of Frs2α-null ICM\",\n      \"journal\": \"Stem Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus genetic KO plus rescue experiment; multiple orthogonal methods establishing pathway order\",\n      \"pmids\": [\"19890878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Fgf4 expressed in muscle positively regulates scleraxis and tenascin expression in chick limb tendons; in muscleless and aneural limbs, these tendon markers are down-regulated, and exogenous FGF4 bead implantation induces scleraxis and tenascin but not Fgf8 in normal, aneural, and muscleless limbs.\",\n      \"method\": \"Muscleless/aneural limb preparation; FGF4 bead implantation; in situ hybridization for tendon markers\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function (muscleless limb) plus gain-of-function (bead implant) with defined molecular readouts; single lab\",\n      \"pmids\": [\"12086472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Misexpression of Fgf-4 in chick limb inhibits myogenesis by downregulating Frek (an FGF receptor expressed in myoblasts) expression; retroviral overexpression of Fgf-4 reduces muscle cell number and inhibits terminal myogenic differentiation in vivo.\",\n      \"method\": \"RCAS retroviral overexpression of Fgf-4; quail/chick transplantation; in situ hybridization for Frek and muscle markers\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function in vivo with cell fate tracking and molecular readouts; single lab\",\n      \"pmids\": [\"11319857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"FGF-4 produced by undifferentiated ICM cells promotes differentiation and migration of parietal endoderm from ICM outgrowths (increasing 92 kDa gelatinase and tPA secretion), and FGFR-3 and FGFR-4 are expressed in blastocyst cells as receptors for FGF-4.\",\n      \"method\": \"Immunosurgical ICM isolation; ICM culture with recombinant FGF-4; gelatinase/tPA secretion assay; receptor expression analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct culture experiment with protein addition and functional readouts; single lab\",\n      \"pmids\": [\"7925026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"FGF-4 does not act as an autocrine growth factor for ES cells in culture; FGF-4-/- ES cells proliferate normally and form complex teratomas. However, FGF-4 is required for the growth/survival of specific differentiated lineages (particularly parietal extraembryonic endoderm) derived from ES cells in vitro.\",\n      \"method\": \"Homologous recombination to generate FGF-4-/- ES cells; proliferation assay; retinoic acid differentiation; FGF-4 rescue\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO ES cells with defined differentiation phenotype plus FGF-4 protein rescue; single lab\",\n      \"pmids\": [\"9441693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Fgf4 is required for left-right (LR) patterning of visceral organs in zebrafish; Fgf4 knockdown randomizes organ laterality and is required for cilia formation in Kupffer's vesicle and for expression of lefty1 in the posterior notochord, establishing a role for Fgf4 in LR axis establishment distinct from Fgf8.\",\n      \"method\": \"Morpholino antisense knockdown of Fgf4 in zebrafish; in situ hybridization for laterality markers (lefty1, lefty2, southpaw, pitx2); cilia analysis in Kupffer's vesicle\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — morpholino knockdown with specific molecular phenotype; single lab but multiple orthogonal readouts\",\n      \"pmids\": [\"19481538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"FGF-4 (hst/HST-1) causes dose-dependent prolactin secretion from rat pituitary cells and increases prolactin transcriptional activity via the rPRL promoter; stable hst transfection of GH4 cells causes enhanced basal PRL secretion, faster proliferation, and more aggressive tumor growth in vivo.\",\n      \"method\": \"Recombinant FGF-4 treatment of pituitary cell cultures; stable transfection of hst; PRL reporter luciferase assay; subcutaneous tumor injection\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function transfection plus reporter assay plus in vivo tumor model; single lab\",\n      \"pmids\": [\"8550832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"O-GlcNAcylation of PKCζ at its phosphorylation site inhibits PKCζ phosphorylation (activation), thereby inhibiting the FGF4-PKCζ-MEK-ERK1/2 signaling pathway in mouse ESCs and maintaining the undifferentiated state.\",\n      \"method\": \"O-GlcNAc site mapping on PKCζ; phosphorylation assays; MEK/ERK1/2 activity measurements; OGT inhibition and overexpression in ESCs\",\n      \"journal\": \"Stem Cell Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PTM identification with functional pathway readout; single lab, multiple biochemical methods\",\n      \"pmids\": [\"29249667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Adenovirus-mediated HST-1 (FGF4) gene transfer in nude mice specifically increases peripheral platelet count and megakaryocyte numbers in bone marrow, with no other major hematological changes.\",\n      \"method\": \"Adenovirus-mediated gene delivery in vivo; complete blood counts; bone marrow histology\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function with specific cellular phenotype; single lab\",\n      \"pmids\": [\"7809043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"HST-1 (FGF4) protein has potent in vivo angiogenic activity demonstrated in the chick chorioallantoic membrane assay and rat cornea assay; NIH3T3 transformants expressing hst-1 form highly vascularized tumors in nude mice.\",\n      \"method\": \"E. coli-expressed recombinant hst-1 protein; CAM angiogenesis assay; rat cornea assay; xenograft tumor model\",\n      \"journal\": \"Cancer Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal in vivo angiogenesis assays plus xenograft; single lab\",\n      \"pmids\": [\"7520355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FGF4 protects the liver from NAFLD/NASH by activating hepatic FGFR4, which triggers a Ca2+/CaMKKβ-dependent AMPK-Caspase 6 signaling axis, leading to enhanced fatty acid oxidation and reduced hepatocellular apoptosis.\",\n      \"method\": \"Hepatic Fgf4 knockout and recombinant FGF4 pharmacological administration in mouse NAFLD/NASH models; FGFR4-specific inhibition; AMPK and Caspase 6 activity assays\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus pharmacological rescue plus pathway inhibition; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"35152446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Hepatic FXR directly targets Fgf4 as a paracrine regulator of bile acid homeostasis; FGF4 signals through FGFR4 to activate an intracellular FGFR4-LRH-1 node that downregulates Cyp7a1 and Cyp8b1, acting as a first-line checkpoint for intrahepatic BA flux upstream of the peripheral FXR-FGF15/19 pathway.\",\n      \"method\": \"Hepatic Fgf4 conditional knockout; FXR ChIP on Fgf4 promoter; FGFR4 inhibition; Cyp7a1/Cyp8b1 expression assays; cholestasis mouse models\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO plus ChIP plus pharmacological inhibition of FGFR4 plus cholestasis model; multiple orthogonal methods in one study\",\n      \"pmids\": [\"39393353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HST-1/FGF-4 protects male germ cells from heat-stress-induced apoptosis; adenoviral FGF-4 overexpression reduces germ cell TUNEL staining, prevents testicular weight loss and sperm count reduction, activates MAPK survival signaling in germ cells, and stimulates lactate production in Sertoli cells.\",\n      \"method\": \"Adenoviral HST-1/FGF-4 delivery to mouse testis; hyperthermia model; TUNEL assay; MAPK pathway analysis; lactate production assay\",\n      \"journal\": \"Experimental Cell Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function with mechanistic readouts (MAPK, lactate); single lab, multiple readouts\",\n      \"pmids\": [\"14980503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Hst-1/FGF-4 antisense oligonucleotides block mouse limb development in an organ culture system, while sense and scrambled oligonucleotides have no effect, demonstrating that Hst-1/FGF-4 is required for limb outgrowth.\",\n      \"method\": \"Antisense oligodeoxynucleotide treatment of mouse limb bud explants in organ culture; limb morphology analysis\",\n      \"journal\": \"Journal of Cell Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — antisense loss-of-function with appropriate controls in organ culture; single lab\",\n      \"pmids\": [\"7642715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FGF-4 regulates proliferation and neuronal differentiation of neural progenitor cells; recombinant FGF-4 promotes formation of large neurospheres with multipotent differentiation ability and significantly promotes neuronal differentiation in clonal neurosphere culture. Fgf-4 mRNA is expressed in postnatal mouse hippocampus, SVZ, and rostral migratory stream.\",\n      \"method\": \"In vitro neurosphere assay with recombinant FGF-4; in situ hybridization of Fgf-4 in brain; clonal neurosphere differentiation assay\",\n      \"journal\": \"FASEB Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — in vitro gain-of-function with functional readout; single lab, single main method\",\n      \"pmids\": [\"16723380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"EC cell-specific expression of K-fgf/FGF4 is controlled by enhancer-like elements in the 3' noncoding region of exon 3 (downstream of the coding sequence), not by upstream promoter sequences; these elements promote expression in undifferentiated EC cells but not in differentiated or non-EC cells.\",\n      \"method\": \"CAT reporter transfections with 3' and 5' K-fgf regulatory element constructs; transfection into undifferentiated vs. differentiated F9 EC cells\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter deletion analysis with functional readout; single lab with systematic mapping\",\n      \"pmids\": [\"2188089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The FGF4 gene (kFGF) is a target for positive transcriptional regulation by Oct4 via an octamer sequence in its distal enhancer; Oct4 but not Oct1 is bound in undifferentiated EC cells, while only Oct1 is present after differentiation.\",\n      \"method\": \"EMSA with nuclear extracts from undifferentiated and differentiated EC cells; reporter assays\",\n      \"journal\": \"Mechanisms of Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA with differentiation-state comparison plus reporter assay; single lab, consistent with PMID 7590241\",\n      \"pmids\": [\"1723621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A highly expressed FGF4 retrogene on canine chromosome 12 (CFA12) is responsible for chondrodystrophy (shortened limbs) and intervertebral disc disease in dogs, with an odds ratio of 51.23 for IVDD, demonstrating that ectopic FGF4 expression causes skeletal dysplasia through FGF signaling pathway abnormalities.\",\n      \"method\": \"Genome-wide association study + whole genome sequencing; segregation analysis; copy number analysis; retrogene expression analysis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — genetic mapping with strong association and expression evidence; mechanistic inference from retrogene expression, not direct functional experiment\",\n      \"pmids\": [\"29073074\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FGF4 is a secreted, heparin-binding growth factor that signals through FGFR1–4 (with tissue-specific engagement gated by heparan sulfate sulfation patterns) to activate autocrine/paracrine mitogenic and survival pathways (RAS-MEK-ERK, AMPK, MAPK) in diverse cellular contexts: it is transcriptionally activated in pluripotent cells by a Sox2/Oct-3 ternary complex on a 3′ distal enhancer (with PARP1-mediated PARylation of Sox2 fine-tuning its activity), and functionally it maintains trophoblast stem cell self-renewal, drives FRS2α→Cdx2→Bmp4 paracrine signaling between ICM and trophectoderm, directs ICM lineage restriction to epiblast vs. primitive endoderm via ERK, acts as the AER wavefront signal (together with FGF8) for limb mesenchyme survival and somitogenesis, induces tendon marker expression and mesenchymal cell chemotaxis in the limb, regulates bile acid homeostasis via an FGFR4–LRH-1–CYP7A1 axis in the liver, and promotes platelet/megakaryocyte production and germ cell survival in vivo.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FGF4 is a secreted, heparin-binding growth factor (~18 kDa) that drives autocrine and paracrine mitogenic and survival signaling by engaging extracellular FGF receptors, and it functions as a master regulator of progenitor maintenance and lineage decisions across early development [#10, #11]. Its activity is gated by heparan sulfate: FGF4 requires a tissue-specific HS sulfation pattern distinct from FGF2, and FGFR2-IIIc binds FGF4/HS complexes broadly while FGFR1-IIIc largely does not, providing context-dependent receptor engagement [#13]. FGF4 expression is itself restricted to pluripotent/undifferentiated cells through a 3' distal enhancer bound cooperatively by Sox2 and Oct-3/4, where only the Sox2/Oct-3 ternary complex activates transcription and PARP1-mediated PARylation of Sox2 tunes enhancer occupancy [#1, #36, #37, #14]. In the early embryo FGF4 maintains trophoblast stem cell self-renewal and supports inner cell mass proliferation, and it directs ICM lineage restriction toward epiblast versus primitive endoderm via ERK signaling, with a FRS2\\u03b1\\u2192ERK\\u2192Cdx2\\u2192Bmp4 paracrine axis relaying the signal between trophectoderm and ICM [#0, #2, #7, #21]. In the developing limb FGF4 acts as an AER-derived signal redundant with FGF8 \\u2014 single Fgf4 loss is dispensable, but combined Fgf4/Fgf8 loss abolishes limb mesenchyme survival, and FGF4 can fully substitute for FGF8 \\u2014 while also promoting mesenchymal proliferation, chemotaxis, and somitogenesis/axial elongation by maintaining presomitic mesoderm and WNT activity [#5, #6, #3, #18, #8, #9]. In adult physiology FGF4 signals through FGFR4 to control hepatic bile acid homeostasis via an FXR\\u2192FGF4\\u2192FGFR4\\u2013LRH-1 axis repressing Cyp7a1/Cyp8b1, and protects the liver in NAFLD/NASH through a Ca2+/CaMKK\\u03b2\\u2013AMPK\\u2013Caspase 6 pathway [#32, #31]. Ectopic FGF4 expression from a canine retrogene causes chondrodystrophy and intervertebral disc disease, linking FGF4 dosage to skeletal dysplasia [#38].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Established the basic biochemical identity of FGF4 as a secreted mitogen, answering what kind of molecule the hst-1 transforming gene encodes.\",\n      \"evidence\": \"Baculovirus expression, heparin-affinity purification, mitogenesis and soft-agar assays\",\n      \"pmids\": [\"2978866\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor identity not defined\", \"No physiological source tissue identified\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Showed FGF4 transforms cells specifically through secretion and extracellular receptor engagement, distinguishing an autocrine extracellular mechanism from intracellular action.\",\n      \"evidence\": \"Signal-peptide deletion and KDEL retention mutants, neutralizing antibody reversal in soft-agar assays; receptor binding/suramin in NIH3T3\",\n      \"pmids\": [\"1990270\", \"2553749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific FGFR engaged not resolved\", \"HS dependence not yet defined\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defined the transcriptional logic restricting FGF4 to pluripotent cells, identifying Sox2/Oct-3 cooperative enhancer binding as the activating mechanism.\",\n      \"evidence\": \"EMSA, reporter assays and mutagenesis in EC cells; earlier 3' enhancer mapping and Oct4 binding studies\",\n      \"pmids\": [\"7590241\", \"2188089\", \"1723621\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address post-translational modulation of the complex\", \"Did not connect to downstream signaling outcomes\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Established FGF4 as essential for postimplantation development by genetic ablation, showing it is required for ICM proliferation.\",\n      \"evidence\": \"Knockout mouse with embryo culture and FGF4 protein rescue\",\n      \"pmids\": [\"7809630\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor and downstream pathway in ICM not defined\", \"Lineage-specification role not yet separated from proliferation\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identified FGF4 as the required niche signal sustaining trophoblast stem cell self-renewal, answering what maintains the undifferentiated TS state.\",\n      \"evidence\": \"TS cell culture with/without FGF4 plus in vivo chimera assay\",\n      \"pmids\": [\"9851926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intracellular signaling cascade not mapped\", \"Source/receptor topology not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolved FGF4/FGF8 redundancy in the limb, showing FGF4 can fully substitute for FGF8 and that combined AER-FGF activity is required for mesenchyme survival.\",\n      \"evidence\": \"Conditional allele swap and double conditional knockout with skeletal/molecular analysis; earlier conditional Fgf4 KO showing dispensability alone\",\n      \"pmids\": [\"15328019\", \"10802662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of each FGF not separated\", \"Receptor usage in mesenchyme not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapped the paracrine signaling order from FGF4 to Bmp4, establishing FGF4\\u2192FRS2\\u03b1\\u2192ERK\\u2192Cdx2\\u2192Bmp4 as the trophectoderm-to-ICM relay.\",\n      \"evidence\": \"FRS2\\u03b1 KO cells, ERK assays, Cdx2 ChIP on Bmp4 promoter, Bmp4 rescue of Frs2\\u03b1-null ICM\",\n      \"pmids\": [\"19890878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor identity upstream of FRS2\\u03b1 not specified\", \"Generalizability beyond TS/ICM not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Clarified that FGF4/ERK controls lineage bias acquisition rather than initial marker activation in the ICM, refining its role in EPI vs PrE segregation.\",\n      \"evidence\": \"Zygotic and maternal/zygotic Fgf4 conditional KO with NANOG/GATA6 immunofluorescence and FGF rescue; parallel PSM and axial-elongation double-KO studies\",\n      \"pmids\": [\"23193166\", \"21368122\", \"22954964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single-cell dynamics of salt-and-pepper resolution not fully resolved\", \"FGF4 vs FGF8 contributions in PSM not individually dissected\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected enhancer regulation to PARP1, showing PARylation of Sox2 tunes FGF4 expression and reprogramming efficiency.\",\n      \"evidence\": \"ChIP, in vitro PARylation, Artd1-/- reprogramming with FGF4 rescue\",\n      \"pmids\": [\"19531481\", \"23939864\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry/sites of Sox2 PARylation in vivo not fully defined\", \"Whether this applies to all FGF4-expressing contexts unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined an adult metabolic role for FGF4 in the liver, establishing an FXR\\u2192FGF4\\u2192FGFR4\\u2013LRH-1 checkpoint for bile acid homeostasis and an AMPK-dependent hepatoprotective axis.\",\n      \"evidence\": \"Hepatic Fgf4 conditional KO, FXR ChIP, FGFR4 inhibition, Cyp7a1/Cyp8b1 assays, cholestasis and NAFLD/NASH models\",\n      \"pmids\": [\"39393353\", \"35152446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crosstalk with peripheral FGF15/19 quantitatively unresolved\", \"Human relevance of hepatic FGF4 axis not established in timeline\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single ligand achieves its many distinct outcomes \\u2014 the precise FGFR/HS combinations and receptor-proximal signaling that distinguish proliferation, survival, chemotaxis, lineage bias, and metabolic checkpoint functions in each tissue \\u2014 remains unresolved.\",\n      \"evidence\": \"No single discovery in the timeline integrates the receptor/HS code with the divergent cellular outputs\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified receptor-output map across tissues\", \"Structural basis of HS-pattern selectivity not determined\", \"Human disease relevance largely inferred from model organisms and canine retrogene\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [10, 11, 13]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [12, 21, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [10, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [21, 28, 31]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 6, 8, 7]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [32, 31]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FGFR2\", \"FGFR1\", \"FGFR4\", \"FGFR3\", \"FRS2\", \"LRH-1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}